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ABSTRACT: Three cationic bis-cyclometallated iridium complexes [Ir(C^N-
ppyMe)2(P^N)][PF6](1-3) with 4-methyl-2-phenylpyridine (ppyMe) as the C^N-
cyclometallated ligands and 8-(diphenylphosphino)quinoline (Ph2Pqn, L1), 2-
(diphenylphosphinoamino)pyridine (Ph2PNHpy, L2) or 2-(diphenylphosphinoamino) 
pyrimidine (Ph2PNHpym, L3) as P^N-ligands, were prepared, and their crystal structures and 
photoluminescence were investigated. The substitution of an "aromatic CAr" (of a quinolyl 
group) by an "NH" bridge between the phosphine and imine ligating units of the P^N ligand 
dramatically changes the luminescence characteristics of the resulting complexes. The 
complexes 2-3 featuring the P-NH-N ligand emit in the blue region, whereas complex 1 
incorporating the P-CAr-N unit displays orange photoluminescence. 
Keywords: Iridium complexes. Bis-cyclometallated complexes. Phosphine ligands. 
Luminescence. Blue phosphors 
 
1. Introduction 
Homoleptic and heteroleptic cyclometallated Ir(III) complexes are well known to emit 
phosphorescence at ambient temperature with high quantum yield. Numerous examples of 
cationic complexes incorporating a combination of two cyclometallated ligands and one 
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diimine (e.g. bipyridine, phenanthroline or their derivatives) have been reported and the 
influence of the substitution of the diimine ligand on the electronic excited states described 
[1]. The emission energy of such heteroleptic complexes is readily fine-tuned by changing the 
nature of the cyclometallated ligand C^N and the diimine ligand. For example, blue and 
green-blue phosphorescent Ir(III) complexes have been reported. The commonly used 
approaches to widen the HOMO-LUMO gap and shift emission further to the blue are either 
the use of electron-withdrawing substituents such as F or CF3 in the metallated aryl ring, 
which lowers the HOMO, or the replacement of the pyridine moiety of the C^N ligands by N-
heterocyclic rings such as pyrazoles and N-heterocyclic carbenes to raise the LUMO [2].  
Another way to increase the energy gap is through the use of non-conjugated ancillary 
diarylphosphine chelates in place of the diimine [3]. Indeed, the π-accepting character of the 
PAr2 group is expected to increase the metal-to-ligand charge-transfer (MLCT) energy level 
resulting in blue-shifted emission. Thus, blue-shifts of the emission maxima have been 
obtained using neutral [4,5] or cationic [6] heteroleptic Ir(III) complexes combining C^N 
ligands with either P^C or P^N chelates. 
On the other hand, P^N ligands such as 8-(diphenylphosphino)quinoline (Ph2Pqn, L1), 2-
(diphenylphosphinoamino)pyridine (Ph2PNHpy, L2) and 8-(diphenylphosphinoamino)-
pyrimidine (Ph2PNHpym, L3) represent an interesting class of heterobidentate ligands that 
have been applied by some of us for the palladium catalyzed methoxy-carbonylation of 
olefins (Scheme 1) [7].   
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Scheme 1. Chemical structures of the P^N ligands used in this study 
 
Having in hand these chelating ligands, we sought to use them for the preparation of 
luminescent cationic Ir(III) complexes 1-3 (Scheme 2). Herein we report their synthesis and 
characterization, as well as their photophysical properties. We show that substitution of an 
"aromatic CAr" (of a quinolyl group) by an "NH" bridge between the phosphine and imine 
ligands of the P^N ligand dramatically changes the luminescence characteristics of the 
resulting complexes. The complexes 2-3 featuring the P-NH-N ligands emit in the blue region, 
whereas the P-CAr-N-incorporating complex 1 displays orange photoluminescence. 
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2. Experimental 
2.1. Materials and general methods 
All manipulations were performed using Schlenk techniques under an Ar atmosphere, but 
the workups were carried out in air. All solvents were dried and purified by standard 
procedures. All starting materials were used as received. Complex [Ir(C^N-Meppy)2(µ-Cl)]2 
(Meppy = 4-methyl-2-phenylpyridine) was prepared following the literature procedure [8]. 
The P^N ligands, Ph2Pqn, Ph2PNHpy and Ph2PNHpym, were synthesized according to 
reported methods [7,9].  
NMR spectra were recorded on Bruker Ascend 400, AV 300 or AV 500 MHz 
spectrometers. UV-visible absorption spectra were recorded using an AnalitikJena Specord 
205 spectrophotometer. High resolution mass spectra (HRMS) were performed on a MS/MS 
MicrO-Tof-Q 2 at the CRMPO (Centre de Mesures Physiques de l’Ouest) in Rennes. 
Elemental analyses were performed on a FlashEA1112 at the CRMPO.  
Steady-state luminescence spectra were measured using a Jobin Yvon FluoroMax-2, fitted 
with a red-sensitive Hamamatsu R928 photomultiplier tube. The spectra shown are corrected 
for the wavelength dependence of the detector, and the quoted emission maxima refer to the 
values after correction.  Phosphorescence lifetimes were measured by time-correlated single-
photon counting following excitation at 374 nm with an EPL-375 pulsed diode laser. The 
emitted light was detected at 90˚ using a Peltier-cooled R928 PMT after passage through a 
monochromator. Spectra at 77 K were obtained with the sample loaded in a 4 mm o.d. quartz 
tube inside a quartz-walled Dewar filled with liquid nitrogen. 
Single crystals for X-ray diffraction studies were grown by slow diffusion of pentane into a 
CH2Cl2 solution of complexes 1-3 at 20°C. All measurements were made in the omega-scan 
technique on a CCD Sapphire 3 Xcalibur diffractometer (Agilent) with graphite 
monochromatized MoKα radiation. The data collection and refinement parameters are 
presented in Table 2. The structures were solved with SIR-97 [10] which reveals the non-
hydrogen atoms of the molecules. The whole structures were refined by full-matrix least-
square techniques on F2, with hydrogens refined using the Riding mode. Structures were 
solved by Patterson or direct methods. The structures were completed by subsequent 
difference Fourier techniques and refined by full-matrix least squares on F2 (SHELXL-97) 
with initial isotropic parameters [11]. Atomic scattering factors were taken from international 
Tables for X-ray crystallography. ORTEP views were realized with PLATON [12]. The 
crystal structures of 1, 2 and 3 have been deposited at the Cambridge Crystallographic Data 
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Centre and allocated the deposition numbers CCDC-938912, CCDC-907692, and CCDC-
912857, respectively. These data can be obtained free of charge at 
www.cccdc.cam.ac.uk/conts/retrieving.html [or from Cambridge Crystallographic Data 
Centre, 12, Union Road, Cambridge CB2 1EZ; Fax: (internat.) +44-1223/336-033; e-mail: 
deposit@ccdc.cam.ac.uk].  
 
2.2. Preparation of complexes 1-3.  
General procedure. The chloride-bridged dimer [Ir(C^N-Meppy)2(?-Cl)]2 (257 mg, 0.228 
mmol), and the appropriate P^N-ligand L (2.1 equiv), and AgPF6 (181 mg 0.716 mmol) were 
suspended in dichloromethane (15 mL). The reaction mixture was stirred under argon for 16 h 
at room temperature. The solution was filtered and the solvent was removed and the product 
was washed with diethyl ether (3 x 10 mL). Crystallization from a CH2Cl2/diethyl ether 
mixture gave the expected compound as a powder  
3. Results and Discussion 
3.1. Synthesis and characterization of Ir(III) complexes 1-3 
The three P^N ligands were prepared following previously reported procedures [7,9]. The 
cationic complexes [Ir(C^N-ppyMe)2(P^N)][PF6](1-3) are readily accessible by treatment of 
the chloro-bridged dimer [Ir(C^N-Meppy)2(µ-Cl)]2 with 2 equivalents of the appropriate P^N 
ligand in the presence of excess AgPF6 to facilitate the removal of the chloride ligands. The 
AgPF6 also ensures that the complexes are isolated as their hexafluorophosphate salts, which 
offer better solubility over the chloride salts. All complexes are isolated in good yield after 
recrystallisation from CH2Cl2/diethyl ether. They were fully characterized by standard 
spectroscopic methods (1H and 31P NMR) and gave satisfactory analysis. In the 31P{1H} NMR 
spectrum of 1 (CD2Cl2), the coordinated phosphine gives rise to a singlet at δ 8.20 ppm, 
which is shifted to higher field in comparison with that of the free ligand L1 (δ (CHCl3) = -
14.20 ppm). 
Complex 1: yellow-green powder (55% yield). 1H NMR (400 MHz, CD2Cl2): 8.60 (d, 1H, 
3J = 8.4 Hz), 8.50-8.46 (m, 2H), 8.37 (d, 1H, 3J = 8.0 Hz), 8.05 (t, 1H, 3J = 7.6 Hz), 7.83-7.76 
(m, 5H), 7.59-7.55 (m, 1H), 7.50-7.41 (m, 4H), 7.31 (s, 1H), 7.15-7.10 (m, 2H), 7.05-6.95 (m, 
4H), 6.86 (td, 2H, 3J = 6.5 Hz, 4J = 2.3 Hz), 6.59 (d, 1H, 3J = 7.2 Hz), 6.46 (d, 1H, 3J = 5.8 
Hz), 6.36-6.32 (m, 3H), 6.22 (td, 1H, 3J = 6.0 Hz, 4J = 2.0 Hz), 2.32 (s, 3H), 2.27 (s, 3H). 
31P{1H} NMR (162 MHz, CD2Cl2): 8.2 (s), -145.0 (q, PF6). HRMS m/z calcd. for 
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C45H36N3P193Ir : 842.22708, found : 842.2270.  Anal. Calcd for C45H36N3F6P2Ir 1.5CH2Cl2: C, 
50.12, H, 3.53, N, 3.77. Found C, 50.25, H, 3.35, N, 3.76. 
Complex 2: yellow powder (75% yield). 1H NMR (400 MHz, CD2Cl2): 8.11 (d, 1H, 3J = 6.0 
Hz), 7.92 (d, 1H, 3J = 3.4 Hz), 7.82-7.66 (m, 6H), 7.54-7.44 (m, 5H), 7.30 (s, 1H), 7.28 (d, 
1H, 3J = 6.0 Hz), 7.11-6.92 (m, 7H), 6.71 (t, 2H, 3J = 9.2 Hz), 6.62-6.56 (m, 3H), 6.52 (dd, 
1H, 3J = 5.8 Hz, 4J = 1.3 Hz), 6.19 (t, 1H, 3J = 5.9 Hz), 2.45 (s, 3H), 2.35 (s, 3H). 31P{1H} 
NMR (162 MHz, CD2Cl2): 48.0 (s), -145.0 (q, PF6). HRMS m/z calcd. for C41H35N4P193Ir : 
807.22233, found: 807.2227. Anal. Calcd for C41H35N4F6P2Ir: C, 51.73, H, 3.71, N, 5.89. 
Found C, 51.87, H, 3.78, N, 5.75. 
Complex 3: yellow green powder (70% yield). 1H NMR (400 MHz, CD2Cl2): 8.60 (s, 1H), 
8.11 (d, 1H, 3J = 6.0 Hz), 7.78 (s, 1H), 7.75-7.67 (m, 5H), 7.59 (t, 1H, 3J = 7.1 Hz), 7.54-7.49 
(m, 3H), 7.40 (d, 1H, 3J = 6.0 Hz), 7.32 (s, 1H), 7.18-7.08 (m, 2H), 7.06-6.94 (m, 5H), 6.78-
6.70 (m, 4H), 6.59-6.55 (m, 2H), 6.20 (t, 1H, 3J = 6.1 Hz), 2.39 (s, 3H), 2.29 (s, 3H). 31P{1H} 
NMR (162 MHz, CD2Cl2): 39.1 (s), -145.0 (q, PF6). HRMS m/z calcd. for C40H34N5P193Ir : 
808.21758, found: 808.2177. Anal. Calcd for C40H34N5F6P2Ir: C, 50.42, H, 3.60, N, 7.35. 
Found C, 49.92, H, 3.46, N, 7.13. 
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Scheme 2 
 
3.2  X-Ray structures 
 
The structures of the three complexes 1-3 were confirmed by X-ray crystal structure analyses, 
as shown in Figure 1. Selected bond length and bond angle data are listed in Tables 1 and 2. 
All complexes reveal a distorted octahedral geometry around iridium, consisting of two 
cyclometallated C^N ligands and one P^N ligand with the phosphorus atom being trans to a 
cyclometallated carbon atom. The ligand arrangement, where the two Ir-C bonds are in 
mutually cis positions, is similar to that of the parent phenylpyridine ligands in many 
heteroleptic Ir(III) complexes such as the diketonate complex Ir(C^N-ppy)2(O^O-acac) [13] 
and the cationic bipyridine derivatives [8]. The N-Ir and C-Ir bond distances involving the 
cyclometallated ligand are in the same range as those reported for related Ir complexes [14].  
The Ir-N3 bond distances (where N3 is the coordinated nitrogen atom of the P^N ligand in 
each case) are longer than those the coordinated Meppy ligand. In the three complexes, both 
the Ir-N3 and the Ir-P bond lengths of the P^N ligand are very similar.. The chelate bite angle 
of the phosphine ligand (∼ 80°) is the same for each complex. For the PPh2Pqn-containing 
complex, the deviations of atoms Ir1 and P1 from the least-square quinolyl ring plane are only 
0.214 and 0.033 Å, respectively. These latter values are comparable to those found in other 
iridium(III) complexes [15]. They indicate that the chelate coordination of Ph2Pqn forms a 
strain-free planar five-membered ring. 
 
Table 1 
Selected bond lengths (Å) for complexes 1-3. 
Bond 1 2 3 
Ir-C1 2.055(3) 2.013(6) 2.029(4) 
Ir-C13 2.017(3) 2.051(4) 2.054(5) 
Ir-N1 2.069(3) 2.052(3) 2.041(4) 
Ir-N2 2.040(3) 2.067(4) 2.057(4) 
Ir-N3 2.173(3) 2.192(4) 2.180(4) 
Ir-P1 2.3404(9) 2.3412(11) 2.3143(12) 
P1-NH  1.696(4) 1.700(4) 
P1-CPh  1.814(4) 1.802(5) 
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a) 
 
b) c) 
 
Fig.1. ORTEP drawing displaying the molecular structure of complexes 1(a), 2 (b) and 3(c) 
with ellipsoids at the 50% probability level. Hydrogen atoms are omitted for clarity.  
 
 
Table 2 
Selected bond angles (°) for complexes 1-3.  
Bond 1 2 3 
C1-Ir-C13 86.70(12) 86.02(17) 88.55(17) 
C1-Ir-N1 79.49(12) 79.79(17) 80.38(17) 
C1-Ir-N2 91.76(12) 167.38(16) 80.38(17) 
C1-Ir-N3 95.96(11) 179.06(15) 174.88(16) 
C1-Ir-P1 177.40(9) 101.43(12) 95.10(13) 
C13-Ir-N1 96.68(11) 89.79(15) 93.11(18) 
C13-Ir-N2 79.97(11) 79.76(16) 78.91(18) 
C13-Ir-N3 174.61(11) 93.05(16) 95.87(15) 
C13-Ir-P1 95.56(9) 172.09(13) 176.29(12) 
N1-Ir-N2 170.84(11) 167.38(16) 171.22(15) 
N1-Ir-N3 88.42(10) 100.26(15) 96.76(15) 
N1-Ir-P1 101.49(8) 88.91(10) 86.87(11) 
N2-Ir-N3 95.24(10) 87.44(18) 87.77(15) 
N2-Ir-P1 87.37(7) 102.40(11) 101.34(11) 
N3-Ir-P1 81.69(8) 79.51(10) 80.45(10) 
NH-P1-CPh  104.6(2) 104.9(2) 
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3.3 Electronic absorption and luminescence properties 
The UV-vis absorption data of complexes 1-3 in CH2Cl2 are summarized in Table 3, and 
the corresponding spectra are shown in Figure 2. The absorption spectra of complexes 1-3 
show intense absorption bands in the higher energy region (λ < 340 nm) which are dominated 
by intra-ligand 1IL (π → π*) transitions of the C^N and P^N ligands, and a moderately 
intense lower-energy absorption band at longer wavelength (around 360 nm) assigned to the 
tail of the  IL transitions overlapping with MLCT dπ(Ir) → π* (C^N and P^N) transitions. 
The spectrum of complex 1 has a weak shoulder extending to longer wavelengths than for 2 
and 3, possibly reflecting the more extended π-conjugation of the chelated quinolylphosphine 
ligand. The spectra of 2 and 3 are very similar to those reported for the related complex 
[Ir(C^N-ppy)(P^N-dppmp)][PF6] having a P^N-2-diphenylphosphinomethylpyridine (dppmp) 
ligand, which contains a saturated "CH2" bridge instead of NH [6].  
 
 
Fig 2. UV-Vis absorption spectra (CH2Cl2, 298 K) for complexes 1-3. 
 
Table 3 
Photophysical data of the investigated iridium(III) complexes. 
 
Cpd λabs / nm  
(ε [M-1cm-1])[a] 
λem / nm[b,c] τ /ns λem at 77 K /nm[c,d] 
 
? [%][e]
1 293sh (22300) 359 
(7130) 
580 
 
1800 
 
500, 530, 567 7.5 
2 296 (20100), 361 
(5920) 
461, 491, 522 270 
 
458, 481, 512 0.68 
 
3 306sh (16800), 362 
(6270) 
460, 493, 526 30 
 
458, 481, 512 0.04 
 
[a] Values refer to solutions in CH2Cl2 at 298 K, except where indicated otherwise. [b] In degassed CH2Cl2 
solutions. [c] ?exc = 365 nm. [d] In EPA  [e] Ru(bpy)3Cl2 was used as the standard (? = 0.028 in air-equilibrated 
water). 
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Upon irradiation, complexes 1-3 are photoluminescent in CH2Cl2 solution at 298 K but 
they display very different emission characteristics depending on the nature of the P^N ligand. 
The luminescence data are listed in Table 3 and the emission spectra are shown in Figure 3. 
Complex 1 displays a broad emission band centred in the orange region of the spectrum at 
590 nm with a lifetime of 1800 ns. The emission is red-shifted compared to related well-
known complexes such as Ir(C^N-ppy)2(O^O-acac) which may be a reflection of a lower-
lying LUMO, localised on the quinolyl group of the P^N ligand as opposed to the pyridyl of 
the C^N ligands. Complexes 2 and 3, on the other hand, emit in the blue spectral region, and 
the spectra display well-resolved structure. The breaking of the conjugation of the P^N bridge 
has an essential impact in determining the nature of the emissive state. The blue emission 
could be attributed to the π accepting properties of the phosphorus, lowering the energy of the 
metal-based orbitals that contribute to the HOMO, whilst the LUMO remains localised on the 
pyridyl rings of the  
C^N ligands. 
 
a) 
 
 
b) 
 
Fig.3 Emission spectra of complexes 1-3 (λex = 365 nm): (a) in CH2Cl2 at 298 K), (b) in EPA, 
at 77 K. 
 
As has frequently been found in other studies aimed at blue emitters, the quantum yield 
falls off and the lifetimes shorten on moving to the blue region, possibly due to quenching of 
the emissive state through close-lying d-d states.  Replacement of a pyridine by a pyrimidine 
ring in 3 has little influence on the emission maxima, but it is striking that the lifetime 
decreases by an order of magnitude.  This could be due to a greater degree of distortion in the 
excited state of 3.  Indeed, close inspection of the spectra of 2 and 3 reveals that, although the 
1 
2 
3 
Wavelength /nm 
1
2
3
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wavelengths of the emission maxima coincide, the relative intensity of the 0-0 vibrational 
band in the spectrum of 3 is substantially smaller than for 2, consistent with a larger degree of 
excited state distortion in the former.  At 77 K, on the other hand, such distortion will be 
impeded, and indeed the spectra of the two complexes under these conditions are essentially 
identical.  
 
The significant variation of emission wavelength between the use of "conjugated" and 
"non-conjugated" ligand P^N ligand has been previously reported. For instance, when 
diphenylnaphtylphosphine (dpn) is used as ancillary ligand in Ir(III) complexes [(C^N- 
Fppy)2Ir(dpn)] [16], a broad emission in the orange region is observed (∼580-630 nm for C^N 
(FppyH = 2-(2,4-difluorophenyl)pyridine) whereas the benzyl analogue [4a,b] gives rise to 
blue-emitting species.  
 
4. Concluding remarks 
Three cationic bis-cyclometallated iridium complexes with 4-methyl-2-phenylpyridine 
(Meppy) as the C^N-cyclometallated ligands and the P^N-ligands, 2-(diphenylphosphino) 
quinoline (Ph2Pqn, L1), 2-(diphenylphosphinoamino)pyridine (Ph2PNHpy, L2) and 2-
(diphenylphosphinoamino) pyrimidine (Ph2PNHpym, L3), were prepared, and their X-ray 
crystallography and photoluminescence were investigated. The above results demonstrate that 
phosphine derivatives, ubiquitous molecules used in catalysis, are also interesting ligands for 
the elaboration of luminescent metal complexes. Moreover, an efficient method to tune the 
color of the emission involves changing the degree of conjugation in these ancillary chelate 
ligands. Thus, we showed that the use of "non-conjugated" and π accepting phosphorus-based 
species as ancillary ligands allows the emission of cationic heteroleptic Ir(III) complexes to be 
shifted to the blue region.  
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Graphical abstract 
Three cationic bis-cyclometallated iridium complexes with 4-methyl-2-phenylpyridine 
(Meppy) as the C^N-cyclometallated ligands and the P^N-ligands, 8-
(diphenylphosphino)quinoline (Ph2Pqn, L1), 2-(diphenylphosphinoamino)pyridine 
(Ph2PNHpy, L2) and 2-(diphenylphosphinoamino)pyrimidine (Ph2PNHpym, L3), were 
prepared, and their X-ray crystallography, and photoluminescence were investigated. The 
complexes 2-3 featuring the P-NH-N ligands emit in the blue region, whereas the P-CAr-N-
incorporating complex 1 displays orange photoluminescence. 
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Fig.3 Emission spectra of complexes 1-3 (λex = 365 nm): (a) in CH2Cl2 at 298 K), (b) in EPA, 
at 77 K. 
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